Adverse events160

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 160

Type	Event	Organ system	Group	Affected	At risk
other	Febrile neutropenia	Blood and lymphatic system disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	2	29
other	Lymphopenia	Blood and lymphatic system disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Petechiae	Blood and lymphatic system disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Arrhythmia	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Atrial fibrillation	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Chest discomfort	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Chest pain	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	2	29
other	Dizziness	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	5	29
other	Dizziness postural	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Dyspnea	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	5	29
other	Dyspnea exertional	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	2	29
other	Fluid overload	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	2	29
other	Palpitations	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Peripheral swelling	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Supraventricular tachycardia	Cardiac disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Deafness	Ear and labyrinth disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Ear infection	Ear and labyrinth disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Ear pain	Ear and labyrinth disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	2	29
other	Hypothyroidism	Endocrine disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29
other	Blepharitis	Eye disorders	Alemtuzumab in Patients With T Cell Large Granular Lymphocytic Leukemia (T-LGL)	1	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00345345/events

API reference For AI assistants

Adverse events160

Sources 3

Read this list from software.